Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lisuride hydrogen maleate

EU orphan designation number: EU/3/11/869   
Active ingredient: Lisuride hydrogen maleate
Indication: Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Sponsor: Sinoxa Pharma GmbH
Königin-Luise-Straße 27, 14195 Berlin, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/05/2011 Orphan designation EMA/OD/138/10 (2011)3495 of 13/05/2011
12/11/2012 Change of name and/or address of sponsor